Alembic Pharmaceuticals posted its results for the quarter ended December 2024 (Q3FY25). Its consolidated net profit tumbled ...

Man Infraconstruction slipped 5.01% to Rs 192.30 after the company reported 2.87% decline in consolidated net profit to Rs 84.03 crore in Q3 FY25 as against Rs 86.51 crore in Q3 FY24.

Titan’s revenue from operations in Q3FY25 is estimated to grow 25% YoY, while its net profit is expected to remain flat due ...

Aditya Birla Capital recorded revenue from operations at Rs 9381.35 crore, up 9.28 per cent as against Rs 8584.50 crore ...

MercadoLibre has robust growth with significant ad revenue gains. See why MELI stock's high P/E ratio is justified, and why ...

Divi's Labs also said in its exchange filing that it has commenced commercial operations from a part of the Phase 1 of the ...

The company's revenue from operations jumped 25 percent year-on-year to Rs 2,319 crore during the quarter under review.

Divi's Laboratories Q3 Results: Divi's Laboratories on Monday reported an 64.5% year-on-year rise in its consolidated net profit (attributable to Shareholders of the Company) for the fiscal's third ...

India's Divi's Laboratories reported a better-than-expected quarterly profit on Monday, aided by strong performance of its business that focuses on customised production of chemical compounds used in ...

Japan’s Mizuho Financial Group, Japan’s third-largest banking group, on Monday (Feb 3) reported a 28% increase in ...

The stocks of the companies announcing Q3 results will be kept under active watch. Notably, markets have been seeing a ...